Forbion Capital Partners
Founded 2006
About Forbion Capital Partners
Forbion Capital Partners is a venture capital firm focused on investing in life sciences companies in drug development as well as MedTech companies addressing high medical needs. Forbion's investment team of nine investment professionals has built an impressive performance track record since the late nineties with successful investments in Rhein Biotech, Crucell, Neutec, Glycart, Borean, Impella, Alantos, Acorda, Fovea and PanGenetics. Current assets under management exceed €400m ($500m), split between three active funds. Finally, Forbion co-manages BioGeneration Ventures, an early stage fund focused on academic spin-outs and seed investments in the Netherlands.
Company Facts
- Founded: 2006
- Legal name: Forbion Capital Partners Management Services B.V.
- Operating status: Operating
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Website: forbion.com
- Phone: +31 35 699 30 00
Social Profiles
Canonical: https://fsome.com/organization/forbion-capital-partners-8267929 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.